BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 22838246)

  • 1. Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study.
    Dantas PR; Maestá I; Cortés-Charry R; Growdon WB; Braga A; Rudge MV; Berkowitz RS
    J Reprod Med; 2012; 57(7-8):305-9. PubMed ID: 22838246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
    Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
    Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of postmolar gestational trophoblastic neoplasia using prophylactic single bolus dose of actinomycin D in high-risk hydatidiform mole: a simple, effective, secure and low-cost approach without adverse effects on compliance to general follow-up or subsequent treatment.
    Uberti EM; Fajardo Mdo C; da Cunha AG; Rosa MW; Ayub AC; Graudenz Mda S; Schmid H
    Gynecol Oncol; 2009 Aug; 114(2):299-305. PubMed ID: 19427681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose actinomycin D: Efficacy in the prophylaxis of postmolar gestational trophoblastic neoplasia in adolescents with high-risk hydatidiform mole.
    Uberti EM; Diestel MC; Guimarães FE; De Nápoli G; Schmid H
    Gynecol Oncol; 2006 Aug; 102(2):325-32. PubMed ID: 16476471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is chemotherapy necessary for patients with molar pregnancy and human chorionic gonadotropin serum levels raised but falling at 6months after uterine evacuation?
    Braga A; Torres B; Burlá M; Maestá I; Sun SY; Lin L; Madi JM; Uberti E; Viggiano M; Elias KM; Berkowitz RS
    Gynecol Oncol; 2016 Dec; 143(3):558-564. PubMed ID: 27640962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study.
    Kim BW; Cho H; Kim H; Nam EJ; Kim SW; Kim S; Kim YT; Kim JH
    Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
    Braga A; Biscaro A; do Amaral Giordani JM; Viggiano M; Elias KM; Berkowitz RS; Seckl MJ
    Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gestational trophoblastic disease: a 21-year review of the clinical experience at an Argentinean public hospital.
    Bianconi MI; Otero S; Moscheni O; Alvarez L; Storino C; Jankilevich G
    J Reprod Med; 2012; 57(7-8):341-9. PubMed ID: 22838252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia?
    Sun SY; Melamed A; Goldstein DP; Bernstein MR; Horowitz NS; Moron AF; Maestá I; Braga A; Berkowitz RS
    Gynecol Oncol; 2015 Jul; 138(1):46-9. PubMed ID: 25969351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal cases of gestational trophoblastic neoplasia over four decades in the Netherlands: a retrospective cohort study.
    Lybol C; Centen DW; Thomas CM; ten Kate-Booij MJ; Verheijen RH; Sweep FC; Ottevanger PB; Massuger LF
    BJOG; 2012 Nov; 119(12):1465-72. PubMed ID: 22925191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptotic index for prediction of postmolar gestational trophoblastic neoplasia.
    Braga A; Maestá I; Rocha Soares R; Elias KM; Custódio Domingues MA; Barbisan LF; Berkowitz RS
    Am J Obstet Gynecol; 2016 Sep; 215(3):336.e1-336.e12. PubMed ID: 27094961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological report on the treatment of patients with gestational trophoblastic disease in 10 Brazilian referral centers: results after 12 years since International FIGO 2000 Consensus.
    Braga A; Uberti EM; Fajardo Mdo C; Viggiano M; Sun SY; Grillo BM; Padilha SL; de Andrade JM; de Souza CB; Madi JM; Maestá I; Silveira E
    J Reprod Med; 2014; 59(5-6):241-7. PubMed ID: 24937964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTEN and MDM2 expression in the prediction of postmolar gestational trophoblastic neoplasia.
    Lertkhachonsuk R; Tantbirojn P; Paiwattananupant K
    J Reprod Med; 2012; 57(7-8):333-40. PubMed ID: 22838251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presentation, medical complications and development of gestational trophoblastic neoplasia of hydatidiform mole after intracytoplasmic sperm injection as compared to hydatidiform mole after spontaneous conception - a retrospective cohort study and literature review.
    Braga A; Andrade T; do Carmo Borges de Souza M; Campos V; Freitas F; Maestá I; Sun SY; Pedrotti LG; Bessel M; Junior JA; Filho JR; Elias KM; Horowitz NS; Berkowitz RS
    Gynecol Oncol; 2023 Mar; 170():179-185. PubMed ID: 36706644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of gestational trophoblastic neoplasia after hCG normalisation according to hydatidiform mole type.
    Schmitt C; Doret M; Massardier J; Hajri T; Schott AM; Raudrant D; Golfier F
    Gynecol Oncol; 2013 Jul; 130(1):86-9. PubMed ID: 23523617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic metastasis in gestational trophoblastic neoplasia: patient characteristics, prognostic factors, and outcomes.
    Barber EL; Schink JC; Lurain JR
    J Reprod Med; 2014; 59(5-6):199-203. PubMed ID: 24937957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial sampling in patients with trophoblastic disease after suction curettage.
    Lertkhachonsuk R; Treratanachat S
    J Reprod Med; 2008 Aug; 53(8):634-8. PubMed ID: 18773630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
    Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
    BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmolar gestational trophoblastic neoplasia: beyond the traditional risk factors.
    Bakhtiyari M; Mirzamoradi M; Kimyaiee P; Aghaie A; Mansournia MA; Ashrafi-Vand S; Sarfjoo FS
    Fertil Steril; 2015 Sep; 104(3):649-54. PubMed ID: 26099850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole].
    Geng S; Feng FZ; Xiang Y; Wan XR; Zhou Y
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):24-7. PubMed ID: 21429430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.